MIDDLE EAST AND AFRICA COUGH SYRUP MARKET 2022-2028

 

 

TABLE OF CONTENTS

1.     MIDDLE EAST AND AFRICA COUGH SYRUP MARKET - SUMMARY

2.     INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE COUGH SYRUP MARKET

2.2. KEY INSIGHTS

2.2.1.    INCREASING DEMAND FOR HERBAL COUGH SYRUPS

2.2.2.    COMPANIES PROVIDE SUGAR-FREE COUGH SYRUPS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.    THREAT OF NEW ENTRANTS

2.3.2.    THREAT OF SUBSTITUTES

2.3.3.    BARGAINING POWER OF BUYERS

2.3.4.    BARGAINING POWER OF SUPPLIERS

2.3.5.    THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY MARKET STRATEGIES

2.6.1.    MERGERS & ACQUISITIONS

2.6.2.    DIVESTITURES

2.7. MARKET DRIVERS

2.7.1.    INCREASING CHRONIC RESPIRATORY DISEASES

2.7.2.    RISE IN OLDER POPULATION

2.8. MARKET CHALLENGES

2.8.1.    OVERDOSE RISK

2.8.2.    STRICT GOVERNMENT REGULATIONS AND RESTRICTIONS

2.9. MARKET OPPORTUNITIES

2.9.1.    INCREASE IN CHILD-FRIENDLY COUGH SYRUP FLAVORS

2.9.2.    GROWING PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS

2.9.3.    SPECIAL PEDIATRIC COUGH SYRUPS

3.     MIDDLE EAST AND AFRICA COUGH SYRUP MARKET OUTLOOK - BY PRODUCT TYPE

3.1. COUGH SUPPRESSANTS/ANTITUSSIVES

3.2. COMBINATION MEDICATIONS

3.3. EXPECTORANTS

4.     MIDDLE EAST AND AFRICA COUGH SYRUP MARKET OUTLOOK - BY AGE GROUP

4.1. ADULT

4.2. PEDIATRIC

5.     MIDDLE EAST AND AFRICA COUGH SYRUP MARKET OUTLOOK - BY DISTRIBUTION CHANNEL

5.1. RETAIL PHARMACY

5.2. HOSPITAL PHARMACY

5.3. ONLINE PHARMACY

6.     MIDDLE EAST AND AFRICA COUGH SYRUP MARKET – COUNTRY OUTLOOK

6.1. UNITED ARAB EMIRATES

6.2. SAUDI ARABIA

6.3. TURKEY

6.4. SOUTH AFRICA

6.5. REST OF MIDDLE EAST & AFRICA

7.     COMPETITIVE LANDSCAPE

7.1. ABBOTT LABORATORIES

7.2. ACELLA PHARMACEUTICALS LLC

7.3. ASTRAZENECA PLC

7.4. CIPLA LIMITED

7.5. DABUR INDIA LTD

7.6. GLAXOSMITHKLINE

7.7. GLENMARK PHARMACEUTICALS LIMITED

7.8. JOHNSON AND JOHNSON

7.9. MERCK KGAA

7.10.               NOVARTIS INTERNATIONAL AG

7.11.               PFIZER INC

7.12.               PROCTOR AND GAMBLE CO

7.13.               RECKITT BENCKISER GROUP PLC

7.14.               SANOFI SA

7.15.               THE HIMALAYA DRUG COMPANY

8.     RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

         

 

LIST OF TABLES

TABLE 1: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: THE COUNTRIES WITH THE LARGEST PERCENTAGE OF TOTAL POPULATION OVER 65 YEARS IN 2020

TABLE 4: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)

TABLE 5: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY AGE GROUP, 2022-2028 (IN $ MILLION)

TABLE 6: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2022-2028 (IN $ MILLION)

TABLE 7: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

 

 

LIST OF FIGURES

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)

FIGURE 3: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS/ANTITUSSIVES, 2022-2028 (IN $ MILLION)

FIGURE 4: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY COMBINATION MEDICATIONS, 2022-2028 (IN $ MILLION)

FIGURE 5: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY EXPECTORANTS, 2022-2028 (IN $ MILLION)

FIGURE 6: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY AGE GROUP, 2021 & 2028 (IN %)

FIGURE 7: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY ADULT, 2022-2028 (IN $ MILLION)

FIGURE 8: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY PEDIATRIC, 2022-2028 (IN $ MILLION)

FIGURE 9: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2021 & 2028 (IN %)

FIGURE 10: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY RETAIL PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 11: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY HOSPITAL PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 12: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY ONLINE PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 13: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 14: UNITED ARAB EMIRATES COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 15: SAUDI ARABIA COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 16: TURKEY COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 17: SOUTH AFRICA COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 18: REST OF MIDDLE EAST & AFRICA COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

 

 

MARKET OUTLOOK

Triton Market Research’s report insinuates that the Middle East and Africa’s cough syrup market is anticipated to advance in terms of revenue at a compound annual growth rate of 2.86% during the forecast years 2022-2028. The United Arab Emirates, South Africa, Turkey, Saudi Arabia, and Rest of Middle East & Africa shape the market in the region.

In the United Arab Emirates, chronic obstructive pulmonary disease, asthma, respiratory allergies, and lung disease are becoming more prevalent. As per estimates, the condition affects around 1.3 million residents. Moreover, the country’s dusty, arid, and sandstorm-prone environment causes significant respiratory issues for residents. Therefore, the rise in respiratory issues creates a profitable market for cough syrup within the UAE.

On the other hand, South Africa faces the burden of chronic respiratory diseases that includes a mix of infectious and non-infectious diseases. The mineworkers in the country face a high risk of these diseases due to a severe work environment. Furthermore, asthma is becoming highly prevalent in urban and rural areas. This rise in respiratory diseases increases the adoption and consumption of cough syrup across the country. Thus, these factors are anticipated to widen the scope and growth of the cough syrup market across South Africa.

 

Get more Insights into the Middle East and Africa Cough Syrup Market:

 

https://www.tritonmarketresearch.com/reports/middle-east-and-africa-cough-syrup-market

 

 

COMPETITIVE OUTLOOK

Leading companies in the cough syrup market are Abbott Laboratories, Cipla Limited, Dabur India Ltd, Johnson and Johnson, and Novartis International AG.

 

 

SEGMENTATION

1.     ABBOTT LABORATORIES

2.     ACELLA PHARMACEUTICALS LLC

3.     ASTRAZENECA PLC

4.     CIPLA LIMITED

5.     DABUR INDIA LTD

6.     GLAXOSMITHKLINE

7.     GLENMARK PHARMACEUTICALS LIMITED

8.     JOHNSON AND JOHNSON

9.     MERCK KGAA

10. NOVARTIS INTERNATIONAL AG

11. PFIZER INC

12. PROCTOR AND GAMBLE CO

13. RECKITT BENCKISER GROUP PLC

14. SANOFI SA

15. THE HIMALAYA DRUG COMPANY